Propofol and SARS-CoV-2 infection.
作者信息
Hirota Kazuyoshi, Lambert David G
机构信息
Department of Anesthesiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
University Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester, UK.
出版信息
Br J Anaesth. 2020 Dec;125(6):e475-e476. doi: 10.1016/j.bja.2020.08.032. Epub 2020 Sep 1.
Abstract
摘要
相似文献
1
Propofol and SARS-CoV-2 infection.丙泊酚与严重急性呼吸综合征冠状病毒2感染
Br J Anaesth. 2020 Dec;125(6):e475-e476. doi: 10.1016/j.bja.2020.08.032. Epub 2020 Sep 1.
2
Propofol infusion syndrome in severe COVID-19.重症新型冠状病毒肺炎中的丙泊酚输注综合征
Br J Anaesth. 2020 Nov;125(5):e441-e442. doi: 10.1016/j.bja.2020.08.020. Epub 2020 Aug 24.
3
Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.药物重新利用研究确定了潜在的新冠病毒抗病毒药物。
JAMA. 2020 Sep 8;324(10):928. doi: 10.1001/jama.2020.15948.
4
Does prolonged propofol sedation of mechanically ventilated COVID-19 patients contribute to critical illness myopathy?对机械通气的新冠肺炎患者进行长时间丙泊酚镇静是否会导致危重病性肌病？
Br J Anaesth. 2020 Sep;125(3):e334-e336. doi: 10.1016/j.bja.2020.05.056. Epub 2020 Jun 10.
5
Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all.新型冠状病毒肺炎危重症患者的镇静：有哪些特殊性？不能一概而论。
Anaesth Crit Care Pain Med. 2020 Jun;39(3):341-343. doi: 10.1016/j.accpm.2020.04.010. Epub 2020 Apr 29.
6
Drug repurposing in the era of COVID-19: a call for leadership and government investment.新冠疫情时代的药物再利用：呼吁领导力与政府投资。
Med J Aust. 2020 Jun;212(10):450-452.e1. doi: 10.5694/mja2.50603. Epub 2020 May 6.
7
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.基于药物再利用的分子对接和动力学模拟预测 SARS-CoV-2 主要蛋白酶的潜在抑制剂的计算机预测。
J Infect Public Health. 2020 Sep;13(9):1210-1223. doi: 10.1016/j.jiph.2020.06.016. Epub 2020 Jun 16.
8
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?基于宿主的治疗药物用于治疗2019冠状病毒病（COVID-19）：抗病毒机制与抗癌机制之间的联系？
Int J Antimicrob Agents. 2020 Sep;56(3):106125. doi: 10.1016/j.ijantimicag.2020.106125. Epub 2020 Jul 30.
9
Repurposing old drugs as antiviral agents for coronaviruses.将老药重新用作冠状病毒的抗病毒药物。
Biomed J. 2020 Aug;43(4):368-374. doi: 10.1016/j.bj.2020.05.003. Epub 2020 May 23.
10
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.干扰素-β-1a 对病毒感染后给药时体外严重急性呼吸综合征冠状病毒 2 的抑制作用。
J Infect Dis. 2020 Aug 4;222(5):722-725. doi: 10.1093/infdis/jiaa350.
引用本文的文献
1
Inhaled Sedation for Invasively Ventilated COVID-19 Patients: A Systematic Review.有创通气的新冠肺炎患者的吸入镇静：一项系统评价
J Clin Med. 2022 Apr 29;11(9):2500. doi: 10.3390/jcm11092500.
2
Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.重症 COVID-19 患者中异氟烷和丙泊酚镇静的比较——一项回顾性病历审查
J Anesth. 2021 Oct;35(5):625-632. doi: 10.1007/s00540-021-02960-6. Epub 2021 Jun 25.
3
Anaesthesia-related drugs and SARS-CoV-2 infection.麻醉相关药物与新型冠状病毒2型感染
Br J Anaesth. 2021 Jul;127(1):e32-e34. doi: 10.1016/j.bja.2021.03.026. Epub 2021 Apr 5.
4
Putative antiviral effects of propofol in COVID-19.丙泊酚对新型冠状病毒肺炎的潜在抗病毒作用。
Br J Anaesth. 2021 May;126(5):e188-e191. doi: 10.1016/j.bja.2021.02.006. Epub 2021 Feb 13.
Zotero 插件